Ziętek Z, Iwan-Ziętek I, Sulikowski T, Sieńko J, Nowacki M, Zukowski M, Kaczmarczyk M, Ciechanowicz A, Ostrowski M, Rość D, Kamiński M
Department of Clinical Anatomy, Pomeranian Medical University, Szczecin, Poland; Clinic of Gastrointestinal Surgery, Pomeranian Medical University, Szczecin, Poland.
Transplant Proc. 2011 Oct;43(8):3008-12. doi: 10.1016/j.transproceed.2011.08.060.
The etiopathogenesis of lymphoceles remains incompletely understood. The aim of our work was to analyze the perturbations of blood coagulation process for their possible impact on the etiology of lymphoceles. Additionally we performed an evaluation of the incidence and effectiveness of treatment methods for lymphoceles.
During 2004 to 2010, we performed 242 kidney transplantations in 92 female and 150 male patients. The hemostatic parameters included concentrations of: antithrombin, plasminogen, thrombin/antithrombin complexes (TAT), prothrombin products F1+2 (F1+2), d-dimers, and plasmin/antiplasmin complexes.
At 7 years follow-up 27 (11%) recipients had developed symptomatic lymphoceles, namely abdominal discomfort, a palpable mess in the lower abdomen, arterial hypertension, infection of the operative site with fever, lymphorrhoea with surgical wound dehiscence, decreased diurnal urine output with an elevated plasma creatinine, voiding problems of urgency and vesical tenesmus, and/or symptoms of deep vein thrombosis. We applied the following methods of treatment aspiration alone, percutaneous drainage, laparoscopic fenestration or open surgery. In two only patients did perform open surgery. Since 2008 we have not performed an aspiration alone because of high rate of recurrence (almost 100%) and abandoned open surgery in favor of a laparoscopic approach. Our minimally invasive surgery includes percutaneous drainage guided by ultrasound and a laparoscopic procedure with 100% effectiveness. The examined hemostatic parameters revealed decreased concentrations of TAT complexes and F1+2 in subjects with lymphocele showing positive predictive values of 33% and 41% respectively. The negative predictive values for TAT complexes and F1+2 were 14% and 10%, respectively, suggesting decreased blood coagulation activity among effected recipients. Altered blood coagulation processes may explain some aspects of the disturbances of postoperative obliteration of damaged lymphatic vessels and formation of pathological lymph collection afterward.
Perturbations of blood coagulation may be one cause for a lymphocele.
淋巴管囊肿的发病机制尚未完全明确。我们研究的目的是分析凝血过程的紊乱情况,探讨其对淋巴管囊肿病因的可能影响。此外,我们还对淋巴管囊肿的治疗方法的发生率和有效性进行了评估。
2004年至2010年期间,我们对92名女性和150名男性患者进行了242例肾移植手术。止血参数包括:抗凝血酶、纤溶酶原、凝血酶/抗凝血酶复合物(TAT)、凝血酶原产物F1+2(F1+2)、D-二聚体和纤溶酶/抗纤溶酶复合物的浓度。
在7年的随访中,27名(11%)受者出现了有症状的淋巴管囊肿,即腹部不适、下腹部可触及肿块、动脉高血压、手术部位感染伴发热、淋巴漏伴手术伤口裂开、日间尿量减少伴血肌酐升高、尿急和膀胱坠胀等排尿问题,和/或深静脉血栓形成的症状。我们采用了以下治疗方法:单纯抽吸、经皮引流、腹腔镜开窗或开放手术。仅2例患者接受了开放手术。自2008年以来,由于复发率高(几乎100%),我们不再单独进行抽吸,并放弃了开放手术,转而采用腹腔镜手术。我们的微创手术包括超声引导下的经皮引流和腹腔镜手术,有效率为100%。检测的止血参数显示,淋巴管囊肿患者的TAT复合物和F1+2浓度降低,阳性预测值分别为33%和41%。TAT复合物和F1+2的阴性预测值分别为14%和10%,提示受影响的受者凝血活性降低。凝血过程的改变可能解释了术后受损淋巴管闭塞障碍和随后病理性淋巴液积聚的某些方面。
凝血紊乱可能是淋巴管囊肿的一个病因。